GCPII inhibition neuroprotective.
Urea-based NAAG analogue exhibited potential inhibition across all GCPII variants.
This lead molecule exhibited strong interactions with both the active Zinc ions.
It satisfied both the Lipinski rule of five and rule of three for drug-likeliness.